Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
|Active Ingredient:||Melatonin 2mg|
|Dosage Form:||Modified release tablet|
|New Zealand Sponsor:||Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics|
|Manufacturers:||Iberfar - Industria Farmaceutica S.A., Queluz de Baixo, Portugal
SwissCo Services AG, Sisseln, Switzerland
Rovi Pharma Industrial Services, S.A., Madrid, Spain
Dated this 3rd day of May 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).